Efficacy of Alpha1-Antitrypsin Augmentation Therapy in Conditions Other Than Pulmonary Emphysema

Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/1750-1172-6-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pulmonary Emphysema and 1-Antitrypsin Deficiency

BMJ
1971English

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha1-Antitrypsin Deficiency and C-Jun

Hepatology
MedicineHepatology
2017English

An Alpha1-Antitrypsin Enhancer Polymorphism Is a Genetic Modifier of Pulmonary Outcome in Cystic Fibrosis

European Journal of Human Genetics
Genetics
2001English

Alpha1-Antitrypsin Deficiency and Liver Disease

BMJ
1981English

PstI Polymorphism of the Alpha1-Antitrypsin-Like Gene

Nucleic Acids Research
Genetics
1989English

A Novel SERPINA1 Mutation Causing Serum Alpha1-Antitrypsin Deficiency

PLoS ONE
Multidisciplinary
2012English

Long-Term Experience in the Treatment of Α1-Antitrypsin Deficiency: 25 Years of Augmentation Therapy

European Respiratory Review
PulmonaryRespiratory Medicine
2015English

Detection of Alpha1-Antitrypsin Genotypes by Analysis of Amplified DNA Sequences

Nucleic Acids Research
Genetics
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy